IndraLab

Statements

Atorvastatin inhibits NFKB1. 1 / 1

| 1

reach

"Although serum MCP-1 and MIF concentrations were not changed by either statins, atorvastatin administration increased PPAR-alpha and -gamma mRNA abundances and decreased NF-kappaB p50, p65, MCP-1 and TNF-alpha mRNA abundances in atherosclerotic lesions."

21481872

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Atorvastatin inhibits NFKB1. 1 / 1

INDRA sources:

Databases

Reading